The effect of granulocyte colony-stimulating factor on engraftment in patients with lymphoproliferative malignancies and solid tumors undergoing autologous peripheral stem cell transplantation

Turkish Journal of Hematology

Volumn 24, Issue 3, 2007, Pages 117-126

  Coha, Božena ^a   Labar, Boris ^b   Gverić Krečak, Velka ^c  

^a DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Sibenik General Hospital   (Croatia)

Author keywords

CD 34 antigen; G CSF; Hematopoietic function recovery; Leukocyte; Mononuclear; Stem cell; Transplantation

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENDER; GRANULOCYTE; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONPARAMETRIC TEST; SOLID TUMOR; THROMBOCYTE;

EID: 35948953266     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz DF, et al. Engraftment after infusion of CD 34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991;77:1717-22.
2. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni M. Circulation of CD 34+ hematopoietic stem cells in peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989;74:1905-14.
3. Debelak-Fehir KM, Catchatourian R, Epstein RB. Hemopoietic colony forming units in fresh and cryopreserved peripheral blood cells of canines and man. Exp Hemat 1975;3:109-16.
4. Spangrude GJ. Biological and clinical aspects of hematopoietic stem cells. Annu Rev Med 1994;45:93-104.
5. Van Epps ED, Bender J, Lee W, Schilling M, Smith A, Smith S, et al. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Blood Cells 1994;20:411-23.
6. Bragger W, Birken R, Bertz H, Hecht T, Pressler K, Frisch J, et al. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP 16, ifosfamide and cisplatin. Br J Heamatol 1993;84:402-7.
7. Verbik DJ, Jackson JD, Pirrucello SJ; Patil KD, Kessinger A, Joshi SS. Functional and phenotypic characterization of human peripheral blood stem cell harvest: a comparative analysis of cells from consecutive collections. Blood 1995;85:1964-70.
8. Shpall EJ, Jones RB, Bearman SI, Franklin A, Archer PG, Curiel T, et al. Transplantation of enriched CD 34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD 34-positive peripheral-blood progenitors and growth factor on engraftment. J Clin Oncol 1994;12:28-36.
9. Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagannath S, et al. Purified CD34+ Lin-THy+ stem cells do not contain clonal myeloma cells. Blood 1995;86:381-9.
10. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-65.
11. Brugger W, Mocklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 β (IL-1β), IL-6, IL-3, interferon-γ, and erythropoietin. Blood 1993;81:2579-84.
12. Berardi A, Wang A, Levine JD, Lopez P, Scaden DT. Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-8.
13. Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hematopoietic stem cell transplantation for lymphoma. Ann Int Med 1992;116:183-9.
14. Haas R, Witt B, Möhle R, Goldschmidt H, Hohaus S, Fruehauf S, et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995;85:3754-61.
15. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-96.
16. Kessinger A, Armitage JO, Landmark JD, Weisenburger DD. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 1986;14:192-6.
17. Henon PR, Eisenmann JC, Beck-Wirth G, Liang H. A two-phase intensive therapeutic approach in high risk myeloma. Follow up. Int J Cell Cloning 1992;10 (Suppl 1):142-4.
18. Bensinnger WI, Longin K, Appelboum F, Rowley S, Weave C, Lilleby K, et al. Peripheral bloot stem cells (PBSCS) collected ofter recombinant granulocyte colony stimulating with the tempo of engraftment after transplantation. Br J Haemabl 1994;87:825-31.
19. Kröger N, Zeller W, Hassan HT, Krüger W, Renges H, Hummen K. Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone. Ann Hematol 1998;76:257-62.
20. Mangan KF, Mullaney MT, Klimpp TR, Goldberg SL, Macdonald JS. A retrospective comparison of three different methods for mobilization of peripheral blood stem cells. Prog Clin Biol Res 1994;389:441-8.
21. Watts MJ, Sullivan AM, Jamieson E, Pearce R, Fielding A, Devereux S, et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor. An analysis of progenitor-cell quantity and quality and factor predicting for these parameters in 101 pretreated patients with malignant lymphoma. J. Clin Oncol 1997;15:535-46.
22. Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol 1995;13:1323-7.
23. Weaver CH, Hazelton B, Birch R, Plamer P, Allen C, Schwartzberg L, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.
24. Stadtmauer EA, Hodi FS, Sickles C, Biggs DD, Mangan P, Buzby G, et al. High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer. Prog Clin Biol Res 1994;389:487-95.
25. Ho AD, Maruyama M, Maghazachi A, Mason JR, Glück S, Corringham ET. Soluble CD4, soluble CD8, soluble CD25, lymphopoietic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation. Blood 1994;84:3550-7.